BMED:NYE-BlackRock Future Health ETF (USD)

ETF | Others |

Last Closing

USD 26.0979

Change

0.00 (0.00)%

Market Cap

USD 4.21M

Volume

113.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

ETFs Containing BMED

EUSC WisdomTree Europe Hedged .. 2.77 % 0.58 %

N/A

USD 0.05B
DIM WisdomTree International .. 0.00 % 0.58 %

N/A

N/A
EESM:F BNP Paribas Easy - MSCI E.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.46% 41% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.46% 41% F 47% F
Trailing 12 Months  
Capital Gain 16.27% 47% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.27% 47% F 52% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -3.96% N/A N/A 19% F
Dividend Return -3.96% N/A N/A 12% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.72% N/A N/A 73% C
Risk Adjusted Return -33.83% N/A N/A 9% A-
Market Capitalization 4.21M 9% A- 3% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.